Jupiter Asset Management Ltd. Grows Stock Position in Mettler-Toledo International, Inc. $MTD

Jupiter Asset Management Ltd. raised its holdings in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 21.8% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 41,257 shares of the medical instruments supplier’s stock after buying an additional 7,382 shares during the period. Jupiter Asset Management Ltd.’s holdings in Mettler-Toledo International were worth $48,465,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. lifted its position in shares of Mettler-Toledo International by 1.2% during the 1st quarter. Vanguard Group Inc. now owns 2,543,365 shares of the medical instruments supplier’s stock valued at $3,003,485,000 after buying an additional 30,535 shares in the last quarter. Bank of New York Mellon Corp lifted its position in shares of Mettler-Toledo International by 71.3% in the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock valued at $1,062,257,000 after acquiring an additional 376,419 shares in the last quarter. Alliancebernstein L.P. raised its stake in Mettler-Toledo International by 21.6% during the 1st quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock valued at $837,653,000 after purchasing an additional 126,147 shares during the period. Price T Rowe Associates Inc. MD grew its holdings in Mettler-Toledo International by 5.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 481,011 shares of the medical instruments supplier’s stock valued at $568,032,000 after buying an additional 25,272 shares in the last quarter. Finally, T. Rowe Price Investment Management Inc. boosted its position in shares of Mettler-Toledo International by 11.9% during the first quarter. T. Rowe Price Investment Management Inc. now owns 406,189 shares of the medical instruments supplier’s stock worth $479,673,000 after acquiring an additional 43,082 shares during the last quarter. 95.07% of the stock is owned by institutional investors.

Insider Activity

In other Mettler-Toledo International news, insider Gerry Keller sold 165 shares of Mettler-Toledo International stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the completion of the transaction, the insider owned 94 shares in the company, valued at approximately $123,012.16. This trade represents a 63.71% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Shawn Vadala sold 300 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $1,325.00, for a total value of $397,500.00. Following the sale, the chief financial officer directly owned 5,095 shares in the company, valued at approximately $6,750,875. This trade represents a 5.56% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.94% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts recently commented on MTD shares. Barclays increased their price target on Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the company an “overweight” rating in a research note on Monday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Mettler-Toledo International in a research note on Wednesday, October 8th. Wells Fargo & Company upped their target price on Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the company an “equal weight” rating in a research note on Monday. Bank of America upped their price target on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a report on Monday, September 22nd. Finally, Stifel Nicolaus raised their price objective on Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the stock a “buy” rating in a report on Monday. Five analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $1,406.50.

Mettler-Toledo International Price Performance

Shares of MTD stock opened at $1,446.25 on Wednesday. The business has a fifty day moving average of $1,326.50 and a 200 day moving average of $1,243.39. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,462.09. The firm has a market capitalization of $29.79 billion, a price-to-earnings ratio of 36.62, a price-to-earnings-growth ratio of 4.19 and a beta of 1.41.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The firm had revenue of $1.03 billion for the quarter, compared to analyst estimates of $997.36 million. During the same quarter in the prior year, the firm earned $10.21 earnings per share. Mettler-Toledo International’s revenue for the quarter was up 7.9% on a year-over-year basis. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. As a group, equities research analysts expect that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.